MB, D., T, P., MP, B., SS, B., P, D., SM, D., . . . MA, D. (2021). Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 19(1), 77. https://doi.org/10.6004/jnccn.2021.0001
Chicago Style (17th ed.) CitationMB, Daly, et al. "Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology." Journal of the National Comprehensive Cancer Network : JNCCN 19, no. 1 (2021): 77. https://doi.org/10.6004/jnccn.2021.0001.
MLA (9th ed.) CitationMB, Daly, et al. "Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 19, no. 1, 2021, p. 77, https://doi.org/10.6004/jnccn.2021.0001.